List of Figures
Figure 1: Global Covid-19 Vaccine Market Size, By Value, 2020-2030 (USD Million)
Figure 2: Global Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 3: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 4: Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 5: Global Domestic Government Health Expenditure as % of GDP, 2015-2018 (In %)
Figure 6: Daily Covid-19 vaccine doses administered per 100 people , Feb 3, 2021 (In Millions)
Figure 7: Total no. of Covid-19 vaccination administered, Feb 3, 2021 (In Millions)
Figure 8: Share of people who received at least one dose of covid-19 vaccine, Feb 3, 2021 (In %)
Figure 9: Share of the population fully vaccinated against covid-19, Feb 3, 2021 (In %)
Figure 10: Global Number of people in extreme poverty due to covid-19, 2015-2020 (In Million)
Figure 11: Global Financial Stimulus Package Provided By Government, By Countries, 2020
Figure 12: Global Number of Intensive Care Beds, 2020 (In Numbers)
Figure 13: Global Number of Confirmed COVID19 Deaths, Feb 2021 (In Per Million People)
Figure 14: Global Covid-19 Vaccine Market, By Product Type, 2024, 2030
Figure 15: Global Covid-19 Vaccine Market, By Multivalent Vaccine, By Value (USD Million), 2020-2030
Figure 16: Global Covid-19 Vaccine Market, By Monovalent Vaccine, By Value (USD Million), 2020-2030
Figure 17: Global Covid-19 Vaccine Market, By Patient Type, 2024, 2030
Figure 18: Global Covid-19 Vaccine Market - By Paediatric, By Value (USD Million), 2020-2030
Figure 19: Global Covid-19 Vaccine Market - By Adult, By Value (USD Million), 2020-2030
Figure 20: Global Covid-19 Vaccine Market, By Senior Citizens, By Value (USD Million), 2020-2030
Figure 21: Global Covid-19 Vaccine Market, By End User, 2024, 2030
Figure 22: Global Covid-19 Vaccine Market, By Hospitals, By Value (USD Million), 2020-2030
Figure 23: Global Covid-19 Vaccine Market, By Clinics, By Value (USD Million), 2020-2030
Figure 24: Global Covid-19 Vaccine Market, By Vaccination Centers, By Value (USD Million), 2020-2030
Figure 25: Global Covid-19 Vaccine Market, By Academic and Research Centers, By Value (USD Million), 2020-2030
Figure 26: Global Covid-19 Vaccine Market, By Others, By Value (USD Million), 2020-2030
Figure 27: Global Covid-19 Vaccine Market, By Region, 2024, 2030
Figure 28: North America Covid-19 Vaccine Market Size, By Value, 2020-2030 (USD Million)
Figure 29: North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 30: North America Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 31: North America Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 32: North America Domestic Government Health Expenditure as % of GDP, 2015-2018 (In %)
Figure 33: North America Number of Intensive Care Beds, 2020 (In Numbers
Figure 34: North America Number of Confirmed COVID19 Deaths, Feb 2021 (In Per Million People)
Figure 35: North America Covid-19 Vaccine Market, By Product, By Value (USD Million), 2020-2030
Figure 36: North America Covid-19 Vaccine Market, By Patient, By Value (USD Million), 2020-2030
Figure 37: North America Covid-19 Vaccine Market, By End user, By Value (USD Million), 2020-2030
Figure 38: Market Opportunity Chart of North America Covid-19 Vaccine Market - By Country, By Value, 2030
Figure 39: North America Covid-19 Vaccine Market, By Country, 2024, 2030
Figure 40: United State Covid-19 Vaccine Market Size, By Value, 2020-2030 (USD Million)
Figure 41: United State Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 42: United State Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 43: United State Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 44: United State Domestic Government Health Expenditure as % of GDP, 2015-2018 (In %)
Figure 45: United Kingdom Covid-19 Vaccine Market, By Product, By Value (USD Million), 2020-2030
Figure 46: United State Covid-19 Vaccine Market, By Patient, By Value (USD Million), 2020-2030
Figure 47: United State Covid-19 Vaccine Market, By End user, By Value (USD Million), 2020-2030
Figure 48: Canada Covid-19 Vaccine Market Size, By Value, 2020-2030 (USD Million)
Figure 49: Canada Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 50: Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 51: Canada Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 52: Canada Domestic Government Health Expenditure as % of GDP, 2015-2018 (In %)
Figure 53: Canada Covid-19 Vaccine Market, By Product, By Value (USD Million), 2020-2030
Figure 54: Canada Covid-19 Vaccine Market, By Patient, By Value (USD Million), 2020-2030
Figure 55: Canada Covid-19 Vaccine Market, By End user, By Value (USD Million), 2020-2030
Figure 56: Europe Covid-19 Vaccine Market Size, By Value, 2020-2030 (USD Million)
Figure 57: Europe Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 58: Europe Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 59: Europe Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 60: Europe Domestic Government Health Expenditure as % of GDP, 2015-2018 (In %)
Figure 61: Europe Number of Intensive Care Beds, 2020 (In Numbers)
Figure 62: Europe Number of Confirmed COVID19 Deaths, Feb 2021 (In Per Million People)
Figure 63: Europe Covid-19 Vaccine Market, By Product, By Value (USD Million), 2020-2030
Figure 64: Europe Covid-19 Vaccine Market, By Patient, By Value (USD Million), 2020-2030
Figure 65: Europe Covid-19 Vaccine Market, By End user, By Value (USD Million), 2020-2030
Figure 66: Market Opportunity Chart of Europe Covid-19 Vaccine Market - By Country, By Value, 2030
Figure 67: Europe Covid-19 Vaccine Market, By Country, 2024, 2030
Figure 68: Germany Covid-19 Vaccine Market Size, By Value, 2020-2030 (USD Million)
Figure 69: Germany Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 70: Germany Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 71: Germany Domestic Private Health Expenditure as % of Current Health
Figure 72: Germany Domestic Government Health Expenditure as % of GDP, 2015-2018 (In %)
Figure 73: Germany Covid-19 Vaccine Market, By Product, By Value (USD Million), 2020-2030
Figure 74: Germany Covid-19 Vaccine Market, By Patient, By Value (USD Million), 2020-2030
Figure 75: Germany Covid-19 Vaccine Market, By End user, By Value (USD Million), 2020-2030
Figure 76: France Covid-19 Vaccine Market Size, By Value, 2020-2030 (USD Million)
Figure 77: France Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 78: France Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 79: France Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 80: France Domestic Government Health Expenditure as % of GDP, 2015-2018 (In %)
Figure 81: France Covid-19 Vaccine Market, By Product, By Value (USD Million), 2020-2030
Figure 82: France Covid-19 Vaccine Market, By Patient, By Value (USD Million), 2020-2030
Figure 83: France Covid-19 Vaccine Market, By End user, By Value (USD Million), 2020-2030
Figure 84: United Kingdom Covid-19 Vaccine Market Size, By Value, 2020-2030 (USD Million)
Figure 85: United Kingdom Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 86: United Kingdom Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 87: United Kingdom Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 88: United Kingdom Domestic Government Health Expenditure as % of GDP, 2015-2018 (In %)
Figure 89: United Kingdom Covid-19 Vaccine Market, By Product, By Value (USD Million), 2020-2030
Figure 90: United Kingdom Covid-19 Vaccine Market, By Patient, By Value (USD Million), 2020-2030
Figure 91: United Kingdom Covid-19 Vaccine Market, By End user, By Value (USD Million), 2020-2030
Figure 92: Switzerland Covid-19 Vaccine Market Size, By Value, 2020-2030 (USD Million)
Figure 93: Switzerland Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 94: Switzerland Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 95: Switzerland Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 96: Switzerland Domestic Government Health Expenditure as % of GDP, 2015-2018 (In %)
Figure 97: Switzerland Covid-19 Vaccine Market, By Product, By Value (USD Million), 2020-2030
Figure 98: Switzerland Covid-19 Vaccine Market, By Patient, By Value (USD Million), 2020-2030
Figure 99: Switzerland Covid-19 Vaccine Market, By End user, By Value (USD Million), 2020-2030
Figure 100: Russia Covid-19 Vaccine Market Size, By Value, 2020-2030 (USD Million)
Figure 101: Russia Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 102: Russia Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 103: Russia Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 104: Russia Domestic Government Health Expenditure as % of GDP, 2015-2018 (In %)
Figure 105: Russia Covid-19 Vaccine Market, By Product, By Value (USD Million), 2020-2030
Figure 106: Russia Covid-19 Vaccine Market, By Patient, By Value (USD Million), 2020-2030
Figure 107: Russia Covid-19 Vaccine Market, By End user, By Value (USD Million), 2020-2030
Figure 108: Asia Pacific Covid-19 Vaccine Market Size, By Value, 2020-2030 (USD Million)
Figure 109: Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 110: Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 111: Asia Pacific Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 112: Asia Pacific Domestic Government Health Expenditure as % of GDP, 2015-2018 (In %)
Figure 113: Asia Number of Intensive Care Beds, 2020 (In Numbers)
Figure 114: Asia Number of Confirmed COVID19 Deaths, Feb 2021 (In Per Million People)
Figure 115: Asia Pacific Covid-19 Vaccine Market, By Product, By Value (USD Million), 2020-2030
Figure 116: Asia Pacific Covid-19 Vaccine Market, By Patient, By Value (USD Million), 2020-2030
Figure 117: Asia Pacific Covid-19 Vaccine Market, By End user, By Value (USD Million), 2020-2030
Figure 118: Market Opportunity Chart of Asia Pacific Covid-19 Vaccine Market - By Country, By Value, 2030
Figure 119: Asia Pacific Covid-19 Vaccine Market, By Country, 2024, 2030
Figure 120: China Covid-19 Vaccine Market Size, By Value, 2020-2030 (USD Million)
Figure 121: China Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 122: China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 123: China Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 124: China Domestic Government Health Expenditure as % of GDP, 2015-2018 (In %)
Figure 125: United Kingdom Covid-19 Vaccine Market, By Product, By Value (USD Million), 2020-2030
Figure 126: United Kingdom Covid-19 Vaccine Market, By Patient, By Value (USD Million), 2020-2030
Figure 127: United Kingdom Covid-19 Vaccine Market, By End user, By Value (USD Million), 2020-2030
Figure 128: Japan Covid-19 Vaccine Market Size, By Value, 2020-2030 (USD Million)
Figure 129: Japan Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 130: Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
Figure 131: Japan Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 132: Japan Domestic Government Health Expenditure as % of GDP, 2015-2018 (In %)
Figure 133: Japan Covid-19 Vaccine Market, By Product, By Value (USD Million), 2020-2030
Figure 134: Japan Covid-19 Vaccine Market, By Patient, By Value (USD Million), 2020-2030
Figure 135: Japan Covid-19 Vaccine Market, By End user, By Value (USD Million), 2020-2030
Figure 136: India Covid-19 Vaccine Market Size, By Value, 2020-2030 (USD Million)
Figure 137: India Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 138: India Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 139: India Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 140: India Domestic Government Health Expenditure as % of GDP, 2015-2018 (In %)
Figure 141: India Covid-19 Vaccine Market, By Product, By Value (USD Million), 2020-2030
Figure 142: India Covid-19 Vaccine Market, By Patient, By Value (USD Million), 2020-2030
Figure 143: IndiaCovid-19 Vaccine Market, By End user, By Value (USD Million), 2020-2030
Figure 144: Market Attractiveness Chart of Global Covid-19 Vaccine Market - By Product, 2030
Figure 145: Market Attractiveness Chart of Global Covid-19 Vaccine Market - By Patient, 2030
Figure 146: Market Attractiveness of Global Covid-19 Vaccine Market - By End User, 2025
Figure 147: Market Attractiveness Chart of Global Covid-19 Vaccine Market - By Region, 2030
Figure 148: Astra Zeneca Plc Corporation Revenue, 2015-2019 (In USD Million)
Figure 149: Astra Zeneca Plc Revenue, By Business Segment, 2018 (In %)
Figure 150: Astra Zeneca Plc Revenue, By Business Segment, 2019 (In %)
Figure 151: Astra Zeneca Plc Net Revenue, By Region, 2018 (In %)
Figure 152: Astra Zeneca Net Revenue, By Region, 2019 (In %)
Figure 153: Johnson & Johnson Inc. Revenue, 2015-2019 (In USD Million)
Figure 154: Johnson & Johnson Inc. Net Revenue, By Business Segment, 2018 (In %)
Figure 155: Johnson & Johnson Inc. Net Revenue, By Business Segment, 2019 (In %)
Figure 156: Johnson & Johnson Inc. Net Revenue, By Region, 2018 (In %)
Figure 157: Johnson & Johnson Inc. Net Revenue, By Region, 2019 (In %)
Figure 158: BioNTech Revenue, 2017-2019 (In USD Million)
Figure 159: BioNTech Net Sales, By Business Segment, 2018 (In %)
Figure 160: BioNTech Net Sales, By Business Segment, 2019 (In %)
Figure 161: Moderna Corporation Revenue, 2016-2019 (In USD Million)
Figure 162: Glaxo Smith Kline Plc Revenue, 2015-2019 (In USD Million)
Figure 163: Glaxo Smith Kline Plc Net Sales, By Business Segment, 2019 (In %)
Figure 164: Glaxo Smith Kline Plc Net Sales, By Business Segment, 2020 (In %)
Figure 165: Glaxo Smith Kline Plc Net Revenue, By Region, 2019 (In %)
Figure 166: Glaxo Smith Kline Plc Net Revenue, By Region, 2020 (In %)
Figure 167: CSL Ltd. Revenue, 2015-2020 (In USD Million)
Figure 168: CSL Ltd. Net Sales, By Business Segment, 2019 (In %)
Figure 169: CSL Ltd. Net Sales, By Business Segment, 2020 (In %)
Figure 170: CSL Ltd. Net Revenue, By Region, 2019 (In %)
Figure 171: CSL Ltd. Net Revenue, By Region, 2020 (In %)
Figure 172: Abbott Laboratories Revenue, 2015-2019 (In USD Million)
Figure 173: Abbott Laboratories Net Sales, By Business Segment, 2018 (In %)s
Figure 174: Abbott Laboratories Net Sales, By Business Segment, 2019 (In %)
Figure 175: Abbott Laboratories Net Revenue, By Region, 2018 (In %)
Figure 176: Abbott Laboratories Net Revenue, By Region, 2019 (In %)
Figure 177: Daiichi Sankyo Company Ltd. Revenue, 2015-2019 (In USD Million)
Figure 178: Daiichi Sankyo Plc Net Revenue, By Region, 2018,2019 (In %)
Figure 179: Astellas Pharma Inc. Revenue, 2015-2019 (In USD Million)
Figure 180: Astellas Pharma Inc. Net Sales, By Business Segment, 2018 (In %)
Figure 181: Astellas Pharma Inc. Net Sales, By Business Segment, 2019 (In %)
Figure 182: Astellas Pharma Inc. Net Revenue, By Region, 2018 (In %)
Figure 183: Astellas Pharma Inc. Net Revenue, By Region, 2019 (In %)
